info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » Healthcare

Healthcare

Host Cell Protein Testing Market By Product & Service (HCP Testing Kits & Reagents, Analytical Instruments, Testing Services); By Technology (ELISA-Based Testing, Mass Spectrometry, Western Blot & Electrophoresis, Other Analytical Methods); By Application (Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Cell & Gene Therapies); By End User (Biopharmaceutical Companies, Contract Development & Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs), Academic & Research Institutes, Regulatory & Government Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Host Cell Protein Testing Market Tracks Biologics Approval Risk and Regulatory Validation Economics

The Global Host Cell Protein Testing Market is estimated at USD 1.08 billion in 2025, and is projected to reach USD 2.46 billi... Read More

Published Date: JUN-2026 | No Of Pages:170 | $ 4485

Cardiac Point of Care (POC) Testing Devices Market By Clinical Biomarker (Troponin Assays, BNP/NT-proBNP Assays, CK-MB & Other Biomarkers, Multiplex Panels, Consumables & Accessories); By Product Type (Handheld/Portable Devices, Compact Tabletop Systems, Wearable Integrated POC Platforms); By Care Setting (Hospitals & Emergency Departments, Ambulatory & Urgent Care Centers, Diagnostic Clinics & Physician Offices, Community & Remote Care Programs, Ambulance & Prehospital Care); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Cardiac POC Testing Devices Market Tracks Acute Care Economics and Rapid Diagnostic Spending

The Global Cardiac Point of Care (POC) Testing Devices Market was valued at USD 2.45 billion in 2025, and is projected to reach USD 5... Read More

Published Date: JUN-2026 | No Of Pages:161 | $ 4485

Diabetic Nephropathy Market By Drug Class (ACE Inhibitors, Angiotensin II Receptor Blockers [ARBs], SGLT2 Inhibitors, Mineralocorticoid Receptor Antagonists [MRAs], Others); By Disease Stage (Early Diabetic Nephropathy [Microalbuminuria], Overt Nephropathy [Macroalbuminuria], Advanced Kidney Disease); By End User (Hospitals, Specialty Nephrology Clinics, Ambulatory Care Centers, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Introduction And Strategic Context

The Global Diabetic Nephropathy Market is projected to witness a steady CAGR of 6.8%, growing from USD 3.9 billion in 2025 to USD 6.2 billion Read More

Published Date: MAY-2026 | No Of Pages:197 | $ 4485

H3 Inverse Agonist Therapeutics Market By Indication (Narcolepsy With Excessive Daytime Sleepiness, Narcolepsy With Cataplexy, Pediatric Narcolepsy, Idiopathic Hypersomnia, Prader-Willi Syndrome Related Sleepiness); By Product Type (Approved Commercial H3 Inverse Agonists, Pipeline H3 Therapeutics); By Age Group (Adult Patients, Pediatric And Adolescent Patients); By Revenue Type (Core Approved Market Revenue, Lifecycle Expansion Revenue, Pipeline Opportunity Revenue); By Geography, Segment Revenue Estimation, Forecast, 2025–2035

Introduction And Strategic Context

The Global H3 Inverse Agonist Therapeutics Market is entering a more commercially defined phase as histamine-based wakefulness therapies gain stronger positioning across specialty neurology and sleep disorder treatme... Read More

Published Date: MAY-2026 | No Of Pages:163 | $ 4485

Animal Intestinal Health Market By Product Type (Probiotics, Prebiotics, Phytogenics and Essential Oils, Organic Acids, Enzymes and Yeast Derivatives); By Animal Type (Poultry, Swine, Ruminants, Aquaculture, Companion Animals); By Function (Gut Flora Stabilization, Feed Conversion Efficiency, Immunity Enhancement, Disease Prevention and Stress Management); By Distribution Channel (Feed Manufacturers, Veterinary Channels, Direct Farm Sales, Online and Retail Pet Channels); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Introduction And Strategic Context

The Global Animal Intestinal Health Market is projected to expand at a CAGR of 7.8%, increasing from USD 4.9 billion in 2025 to USD 8.3 billion by 2032Read More

Published Date: MAY-2026 | No Of Pages:164 | $ 4485

Radiosensitizer Market By Drug Type (Chemotherapy-Based Radiosensitizers, Hypoxia-Targeted Radiosensitizers, Nanoparticle and Targeted Radiosensitizers, Immunotherapy-Linked Radiosensitizers); By Mechanism of Action (DNA Damage Enhancement, Hypoxia Modification, Cell Cycle Regulation, Immune Microenvironment Modulation); By Cancer Type (Head and Neck Cancer, Glioblastoma and Brain Tumors, Cervical Cancer, Lung Cancer, Gastrointestinal and Rectal Cancers); By End User (Cancer Hospitals and Oncology Centers, General Hospitals, Academic and Research Institutes, Ambulatory Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Introduction And Strategic Context

The Global Radiosensitizer Market is projected to expand at a CAGR of 6.8%, increasing from USD 2.4 billion in 2025 to USD 3.8 billion by 2032, acco... Read More

Published Date: MAY-2026 | No Of Pages:160 | $ 4485

Therapeutic Robots Market By Product Type (Rehabilitation Robots, Assistive Robots, Social & Cognitive Robots, Robotic Prosthetics & Orthotics); By Application (Neurological Rehabilitation, Orthopedic Rehabilitation, Elderly Care, Autism & Cognitive Therapy, Others); By End User (Hospitals & Rehabilitation Centers, Home Care Settings, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Therapeutic Robots Market: Reimbursement Expansion and High-Intensity Rehabilitation Shift Robotics from Pilot Use to Funded Care

The Global Therapeutic Robots Market is independently estimated at USD 1.05 billion in 2025 and is proje... Read More

Published Date: JUL-2026 | No Of Pages:198 | $ 4485

Compound Management Market By Product Type (Systems, Consumables, Services); By Application (Drug Discovery, Biochemical Screening, Genomics Research); By End User (Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Introduction And Strategic Context

The Global Compound Management Market is projected to expand at a CAGR of 11.2% , rising from USD 1.6 billion in 2025 to USD 3.4 billion by ... Read More

Published Date: MAY-2026 | No Of Pages:158 | $ 4485

Engineered Cytokine Immunotherapy Market By Cytokine Class (IL-2 Based Therapies, IL-15 Based Therapies, IL-12 Based Therapies, IL-10 and Other Cytokines); By Engineering Strategy (Receptor-Biased Cytokines, Half-Life Extended Cytokines, Tumor-Activated or Masked Cytokines, Immunocytokine Fusion Constructs); By Clinical Application (Monotherapy Use, Combination with Checkpoint Inhibitors, Combination with Cell Therapies, Combination with Bispecifics and ADCs); By Route of Administration (Intravenous Administration, Subcutaneous Administration, Intratumoral Administration, Other Routes); By Development Stage (Preclinical, Phase 1, Phase 2, Phase 3 and Late Stage); By Geography, Segment Revenue Estimation, Forecast, 2025–2035

Engineered Cytokine Immunotherapy Market: Next-Generation Immune Activation Moves Beyond Legacy IL-2 Toxicity (Last Updated on: June-2026)

The Global Engineered Cytokine Immunotherapy Market is projected to expand at a CAGR of 13.8%, increasing from USD 2.9 billi... Read More

Published Date: MAY-2026 | No Of Pages:170 | $ 2700

Personal Emergency Response Systems Market By Product Type (In-Home Systems, Mobile Systems, Wearable Devices); By Connectivity Type (Landline-Based, Cellular-Based, App-Connected Platforms); By End User (Home-Based Users, Assisted Living Facilities, Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Introduction And Strategic Context

The Global Personal Emergency Response Systems Market is projected to grow at a CAGR of 6.8%, rising from USD 8.4 billion in 2025 to USD 13.... Read More

Published Date: MAY-2026 | No Of Pages:200 | $ 4485